Search Results - "Bhama, J"

Refine Results
  1. 1

    Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients by Ezzelarab, M. B., Zhang, H., Guo, H., Lu, L., Zahorchak, A. F., Wiseman, R. W., Nalesnik, M. A., Bhama, J. K., Cooper, D. K. C., Thomson, A. W.

    Published in American journal of transplantation (01-07-2016)
    “…The ability of regulatory T cells (Treg) to prolong allograft survival and promote transplant tolerance in lymphodepleted rodents is well established. Few…”
    Get full text
    Journal Article
  2. 2

    Ruptured Intracranial Mycotic Aneurysm in Infective Endocarditis With Left Ventricular Assist Device and Implantable Cardiac Defibrillator Device: A Clinical Course by Voruganti, D., Gajurel, K., Bhama, J.K., Cotarlan, V.

    Published in Transplantation proceedings (01-12-2018)
    “…We report the first case of a ruptured intracranial aneurysm-related Staphylococcus epidermidis bacteremia in a patient supported by a continuous flow left…”
    Get full text
    Journal Article
  3. 3

    Lung Transplantation in Patients With Prior Cardiothoracic Surgical Procedures by Shigemura, N., Bhama, J., Gries, C. J., Kawamura, T., Crespo, M., Johnson, B., Zaldonis, D., Pilewski, J., Toyoda, Y., Bermudez, C.

    Published in American journal of transplantation (01-05-2012)
    “…The full spectrum of prior cardiothoracic procedures in lung transplant candidates and the impact of prior procedures on outcomes after lung transplantation…”
    Get full text
    Journal Article
  4. 4

    Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs by Iwase, H, Ekser, B, Satyananda, V, Zhou, H, Hara, H, Bajona, P, Wijkstrom, M, Bhama, J.K, Long, C, Veroux, M, Wang, Y, Dai, Y, Phelps, C, Ayares, D, Ezzelarab, M.B, Cooper, D.K.C

    Published in Transplant immunology (01-03-2015)
    “…Abstract Background In the pig-to-nonimmunosuppressed baboon artery patch model, a graft from an α1,3-galactosyltransferase gene-knockout pig transgenic for…”
    Get full text
    Journal Article
  5. 5

    A Novel Dual Ex Vivo Lung Perfusion Technique Improves Immediate Outcomes in an Experimental Model of Lung Transplantation by Tanaka, Y., Noda, K., Isse, K., Tobita, K., Maniwa, Y., Bhama, J. K., D'Cunha, J., Bermudez, C. A., Luketich, J. D., Shigemura, N.

    Published in American journal of transplantation (01-05-2015)
    “…The lungs are dually perfused by the pulmonary artery and the bronchial arteries. This study aimed to test the feasibility of dual‐perfusion techniques with…”
    Get full text
    Journal Article
  6. 6

    Epidemiology and Outcomes of Deep Surgical Site Infections Following Lung Transplantation by Shields, R. K., Clancy, C. J., Minces, L. R., Shigemura, N., Kwak, E. J., Silveira, F. P., Abdel‐Massih, R. C., Bhama, J. K., Bermudez, C. A., Pilewski, J. M., Crespo, M., Toyoda, Y., Nguyen, M. H.

    Published in American journal of transplantation (01-08-2013)
    “…We conducted a retrospective study of deep surgical site infections (SSIs) among consecutive patients who underwent lung transplantation (LTx) at a single…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The Impact of HeartMate 3 Speed on Outcomes in the Momentum 3 Clinical Trial by Haft, J.W., Silvestry, S.C., Ransom, J.M., Itoh, A., Lowes, B., Katz, J.N., Bhama, J.K., Lee, S., Rapkin, J., Franke, A., Estep, J.D.

    “…Durable continuous flow left ventricular assist devices (LVADs) operate at a fixed speed set by the clinician. Within Momentum 3, a large multicenter clinical…”
    Get full text
    Journal Article
  9. 9

    Ex Vivo‐Expanded Cynomolgus Macaque Regulatory T Cells Are Resistant to Alemtuzumab‐Mediated Cytotoxicity by Dons, E. M., Raimondi, G., Zhang, H., Zahorchak, A. F., Bhama, J. K., Lu, L., Ezzelarab, M., Ijzermans, J. N. M., Cooper, D. K. C., Thomson, A. W.

    Published in American journal of transplantation (01-08-2013)
    “…Alemtuzumab (Campath‐1H) is a humanized monoclonal antibody (Ab) directed against CD52 that depletes lymphocytes and other leukocytes, mainly by…”
    Get full text
    Journal Article
  10. 10

    Predicting RV Failure after LVAD Implantation: Utility of Echocardiographic Strain and Defining RV Failure by Link, C.B, Kormos, R, Jackson, K, Teuteberg, J, Bhama, J, Bermudez, C, Simon, M.A

    “…Purpose Post-operative right ventricular failure (RVF) is a major source of morbidity and mortality in left-ventricular assist device (LVAD) recipients…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Successful Lung Retransplantation After Extended Use of Extracorporeal Membrane Oxygenation as a Bridge by Shigemura, N, Bermudez, C, Bhama, J, Bonde, P, Thacker, J, Toyoda, Y

    Published in Transplantation proceedings (01-06-2011)
    “…Abstract Redo lung transplantation remains a major clinical challenge and its indication for patients with early allograft dysfunction is difficult to…”
    Get full text
    Journal Article
  16. 16

    Impact of Early Adverse Events (AE’s) on Later Mortality in Patients Supported by Continuous-Flow Ventricular Assist Devices (CF-VAD) by Jackson, K, McAnaney, C, Teuteberg, J, Dew, M.A, Bhama, J, Bermudez, C, Ramani, R, McNamara, D, Kormos, R

    “…Purpose INTERMACS data show that select AE’s lead to higher mortality during VAD support. However, the extent to which these AE’s experienced early (within 60…”
    Get full text
    Journal Article
  17. 17

    Effect of Blood Pressure (BP) Control in Continuous Flow Left Ventricular Assist Devices (CF-LVAD) on Aortic Insufficiency (AI) and Neurologic Events by Lampert, B.C, Shullo, M.A, Kunz, N, Lockard, K, Allen, C, Bhama, J, Bermudez, C, Kormos, R, Teuteberg, J.J

    “…Purpose Hypertension affects CF-LVADs by increasing afterload and may increase risk of AI and stroke. The effect of BP control on these adverse events has not…”
    Get full text
    Journal Article
  18. 18

    Post Discharge Non-Compliance Increases Risk of Left Ventricular Assist Device (LVAD) Malfunction but Does Not Affect Survival by Hackmann, A, Lockard, K, Allen, C, Kunz, N, Jackson, K, Bhama, J, Bermudez, C, Teuteberg, J, Kormos, R

    “…Purpose Pre-implant counseling of LVAD patients stresses the importance of following established protocols of medical, social and therapeutic behaviors…”
    Get full text
    Journal Article
  19. 19

    Differential Response to Afterload in Axial and Centrifugal Continuous Flow Left Ventricular Assist Devices (CV-LVAD) by Lampert, B.C, Eckert, C, Shullo, M.A, Scanlon, A, Weaver, S, Bhama, J, Bermudez, C, Kormos, R, Teuteberg, J.J

    “…Purpose CF-LVADs generate a specific flow for a given pressure differential across the pump. Implications of difference between afterload sensitivity of axial…”
    Get full text
    Journal Article
  20. 20